STS/ACC TVT Registry
About the Registry
Created by a collaboration between the Society for Thoracic Surgeons (STS) and the American College of Cardiology(ACC), the STS/ACC TVT RegistryTM monitors patient safety and real-world outcomes related to transcatheter valve replacement and repair procedures – emerging treatments for valve disease patients. Employing state-of-the-art heart valve technology, transcatheter heart valve procedures provide new treatment options for patients who are not eligible for conventional heart valve replacement or repair surgery.
The TVT Registry has been approved by the Centers for Medicare and Medicaid Services (CMS) to meet the registry requirements outlined in the national coverage determination for transcatheter aortic valve replacement (TAVR) and transcatheter edge-to-edge repair (TEER).
An Invaluable Data Source
Analysis of TVT Registry data allows the cardiovascular profession and medical community to understand how transcatheter heart valve procedures are being deployed throughout the U.S., and what impact they will have on patient outcomes as they become more prevalent. Data from the registry also assists the medical device industry and the FDA in surveillance of the quality, safety and efficacy of new medical devices.
Employing Key Experience
The TVT Registry was developed through a partnership between the STS and ACC. The TVT Registry is backed by a breadth of expertise and resources, including the Federal Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS) and with input from the Society for Cardiovascular Angiography and Intervention (SCAI) and the American Association for Thoracic Surgery (AATS).
View a list of current TVT Registry participants
Back to Top